All entries by this author

Has Stephen Stahl Gone Off the Deep End? You Decide

Aug 31st, 2011 | By

A reader of my blog alerted me to this rambling blog post by Stephen Stahl on his NEI blog. I’ve pasted his article and my response below–or you can read the whole thing on his site. I’ll be curious to hear your thoughts.  Here is Dr. Stahl’s post, dated August 23 2011: “Are future psychiatric
[continue reading...]

Share


Dr. Stahl’s Medical Writer Fights Back

Aug 31st, 2011 | By

Dr. Stahl’s controversial post on the evils of pharmascolds and antipsychiatry has attracted nearly as many comments as all of his prior blog posts combined. Most of the comments have been highly critical of his viewpoint. But we have yet to hear a response from the man himself. However, his medical writer, Debbi Ann Morrissette,
[continue reading...]

Share


Syracuse Restaurant Becomes “Pharmaceutical Dinner Facility”

Aug 18th, 2011 | By

In a rather embarrassing attempt to raise revenues, a restaurant in Syracuse, New York, is now explicitly marketing itself as a purveyor of drug company dinners. Francesca’s Cucina, “Located in the heart of Syracuse’s Little Italy,” according to its website, offers a private banquet room, a private outdoor courtyard, and regular tables and a bar
[continue reading...]

Share


Apres le Deluge: The CEJA Spin Cycle Begins

Jun 24th, 2011 | By

When the AMA adopted the 5th version of the CEJA report on industry-funded CME, it seemed clear that this was an ominous and very bad sign for the future of industry-funded CME. I already posted my take on the report here (short version: say goodbye to most industry CME). Now we are beginning to see
[continue reading...]

Share


AMA Votes to Discourage Commercial Support of CME

Jun 21st, 2011 | By

Something huge happened yesterday at the American Medical Association House of Delegates meeting in Chicago. Although the meaning of what happened will be spun throughout the blogosphere, twittersphere, and schmuckosphere, the bottom line is that the AMA just voted most commercial funding of CME out of existence. Specifically, the delegates voted to approve a report
[continue reading...]

Share


A Review of QuantiaMD: Good Content, Murky Firewalls, and Hypo-Disclosure

May 16th, 2011 | By

There are a number of new and rapidly growing physician social networking sites, and two of the largest are Sermo and QuantiaMD. They both offer tempting packages of free information to doctors, including CME. When stuff is free to you, someone else is paying for it. That “someone” has a stake in the content, and
[continue reading...]

Share


Lub-dub, Lub-dub, Lub-dub…KA-CHING!

May 6th, 2011 | By

In a fascinating series of articles released yesterday, ProPublica details how a heretofore obscure medical organization, the Heart Rhythm Society, pulls drug and device company cash in hand over fist. You’ll find the main article here, along with links to several companion pieces, my favorite being this devilishly fun interactive piece in which you can
[continue reading...]

Share


ACCME Seeks to Hide Drug Company Disclosures in the Fine Print

May 4th, 2011 | By

In an absolutely perplexing move, Dr. Murray Kopelow and the ACCME are proposing a revision to their Standards for Commercial Support that will undermine those standards. Currently, when an education company solicits money from industry to underwrite a course for doctors, they must disclose this inherent conflict of interest, and they often do so by
[continue reading...]

Share


“Performance Improvement” CME, Brought To You By Medscape and Eli Lilly

Apr 17th, 2011 | By

Performance Improvement CME has become all the rage in the world of continuing medical education. Otherwise known as PI CME, it is being touted by the AMA as the next big thing in medical education. You can read an AMA white paper about it here. Not all medical specialty organizations actually require that physicians complete
[continue reading...]

Share


“Medical Education Forum”? Or a Dying Industry’s Last Gasp?

Jan 5th, 2011 | By

I just received the email below because I’m a member of a CME industry group, most of whose members depend on industry funding for their existence. It’s an invitation to a meeting in Philadelphia where stakeholders in commercial CME will try to figure out how to stem the hemorrhage of money out of their ethically
[continue reading...]

Share